Search Results - "Schilling, William H.K."

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    The relationship between viral clearance rates and disease progression in early symptomatic COVID-19: a systematic review and meta-regression analysis by Singh, Shivani, Boyd, Simon, Schilling, William H K, Watson, James A, Mukaka, Mavuto, White, Nicholas J

    Published in Journal of antimicrobial chemotherapy (02-05-2024)
    “…Effective antiviral drugs accelerate viral clearance in acute COVID-19 infections; the relationship between accelerating viral clearance and reducing severe…”
    Get full text
    Journal Article
  2. 2

    Does hydroxychloroquine still have any role in the COVID-19 pandemic? by Schilling, William Hk, White, Nicholas J

    Published in Expert opinion on pharmacotherapy (03-07-2021)
    “…: The 4-aminoquinolines, chloroquine, and hydroxychloroquine have been used for over 70 years for malaria and rheumatological conditions, respectively. Their…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Reflections on Participation in a Trial on Hydroxychloroquine as Prevention for COVID-19 among Health Workers in Niger by Kabore, Youssouf, Vatrinet, Renaud, Guindo, Ousmane, Moussa, Souleymane H, Schilling, William H K, Grais, Rebecca F

    “…In 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a rapidly emerging virus causing the coronavirus disease 2019 (COVID-19) pandemic, had…”
    Get full text
    Journal Article
  5. 5

    Blood culture negative endocarditis in the modern era of 16S rRNA sequencing by Godfrey, Rebecca, Curtis, Sally, Schilling, William HK, James, P Rachael

    Published in Clinical medicine (London, England) (01-07-2020)
    “…Blood culture negative endocarditis (BCNE) accounts for up to 20% of infective endocarditis. While the most common cause of BCNE remains the initiation of…”
    Get full text
    Journal Article
  6. 6

    Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial by Schilling, William H K, Jittamala, Podjanee, Watson, James A, Boyd, Simon, Luvira, Viravarn, Siripoon, Tanaya, Ngamprasertchai, Thundon, Batty, Elizabeth M, Cruz, Cintia, Callery, James J, Singh, Shivani, Saroj, Manisaree, Kruabkontho, Varaporn, Ngernseng, Thatsanun, Tanglakmankhong, Nuttakan, Tubprasert, Jaruwan, Abdad, Mohammad Yazid, Madmanee, Wanassanan, Kouhathong, Jindarat, Suwannasin, Kanokon, Pagornrat, Watcharee, Piaraksa, Nattaporn, Hanboonkunupakarn, Pongtorn, Hanboonkunupakarn, Borimas, Poovorawan, Kittiyod, Potaporn, Manus, Srisubat, Attasit, Loharjun, Bootsakorn, Taylor, Walter R J, Chotivanich, Vasin, Chotivanich, Kesinee, Imwong, Mallika, Pukrittayakamee, Sasithon, Dondorp, Arjen M, Day, Nicholas P J, Teixeira, Mauro M, Piyaphanee, Watcharapong, Phumratanaprapin, Weerapong, White, Nicholas J, White, Nicholas J, Schilling, William HK, Phumratanaprapin, Weerapong, Luvira, Viravarn, Callery, James J, Day, Nicholas PJ, Pukrittayakamee, Sasithon, Boyd, Simon, Cruz, Cintia, Dondorp, Arjen M, Taylor, Walter RJ, Watson, James A, Piyaphanee, Watcharapong, Poovorawan, Kittiyod, Ngamprasertchai, Thundon, Siripoon, Tanaya, Hanboonkunupakarn, Borimas, Chotivanich, Kesinee, Jittamala, Podjanee, Imwong, Mallika, Thaipadungpanit, Janjira, Ekkapongpisit, Maneerat, Kruabkontho, Varaporn, Ngernseng, Thatsanun, Tubprasert, Jaruwan, Abdad, Mohammad Yazid, Batty, Elizabeth M, Singh, Shivani, Chotivanich, Vasin, Ruksakul, Wiroj, Sangketchon, Chunlanee, Hanboonkunupakarn, Pongtorn, Sookprome, Sakol, Teixeira, Mauro, Almeida, Pedro J, Aguiar, Renato S, Santos, Franciele, Ashley, Elizabeth, Vongsouvath, Manivanh, Phommasone, Koukeo, Dubot-Pérès, Audrey, Vidhamaly, Sisouphanh, Chingsanoon, Ammala, Bisayher, Sixiong, Chommanam, Danoy, Evans, Terry John, Vidhamaly, Vayouly, Boutthasavong, Latsaniphone, Mayxay, Mayfong, Potaporn, Manus, Srisubat, Attasit, Loharjun, Bootsakorn

    Published in The Lancet infectious diseases (01-01-2024)
    “…Molnupiravir and ritonavir-boosted nirmatrelvir are the two leading oral COVID-19 antiviral treatments, but their antiviral activities in patients have not…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV) by Wongnak, Phrutsamon, Schilling, William H K, Jittamala, Podjanee, Boyd, Simon, Luvira, Viravarn, Siripoon, Tanaya, Ngamprasertchai, Thundon, Batty, Elizabeth M, Singh, Shivani, Kouhathong, Jindarat, Pagornrat, Watcharee, Khanthagan, Patpannee, Hanboonkunupakarn, Borimas, Poovorawan, Kittiyod, Mayxay, Mayfong, Chotivanich, Kesinee, Imwong, Mallika, Pukrittayakamee, Sasithon, Ashley, Elizabeth A, Dondorp, Arjen M, Day, Nicholas P J, Teixeira, Mauro M, Piyaphanee, Watcharapong, Phumratanaprapin, Weerapong, White, Nicholas J, Watson, James A, Callery, James, Cruz, Cintia, Taylor, Walter, Thaipadungpanit, Janjira, Ekkapongpisit, Maneerat, Kruabkontho, Varaporn, Ngernseng, Thatsanun, Tubprasert, Jaruwan, Abdad, Mohammad, Keayarsa, Srisuda, Anunsittichai, Orawan, Hongsuwan, Maliwan, Singhaboot, Yutatirat, Madmanee, Wanassanan, Tuntipaiboontana, Runch, Promsongsil, Amornrat, Saroj, Manisaree, Suwannasin, Kanokon, Beer, Ellen, Asawasriworanan, Tanatchakorn, Blacksell, Stuart, Panapipat, Salwaluk, Waithira, Naomi, Tarning, Joel, Tanglakmankhong, Nuttakan, Almeida, Pedro J, Aguiar, Renato S, Ascencao, Fernando, Esper, Lisia, Vongsouvath, Manivanh, Phommasone, Koukeo, Dubot-Pérès, Audrey, Vidhamaly, Sisouphanh, Chingsanoon, Ammala, Bisayher, Sixiong, Chommanam, Danoy, Evans, Terry, Vidhamaly, Vayouly, Boutthasavong, Latsaniphone, Vongphachanh, Susath, Potaporn, Manus, Srisubat, Attasit, Loharjun, Bootsakorn, Beg, M Asim, Kazi, Abdul Momin, Qamar, Farah, Ghanchi, Najia, Mahmood, Syed Faisal, Hanboonkunupakarn, Pongtorn, Sookprome, Sakol, Chotivanich, Vasin, Ruksakul, Wiroj, Sangketchon, Chunlanee

    Published in The Lancet infectious diseases (01-09-2024)
    “…Effective antiviral drugs prevent hospitalisation and death from COVID-19. Antiviral efficacy can be efficiently assessed in vivo by measuring rates of…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Cutaneous stigmata associated with insulin resistance and increased cardiovascular risk by Schilling, William H. K., Crook, Martin A.

    Published in International journal of dermatology (01-09-2014)
    “…Certain cutaneous conditions have been reported to be associated with diabetes mellitus, insulin resistance, and metabolic syndrome. In this novel review…”
    Get full text
    Journal Article
  12. 12

    The WHO guideline on drugs to prevent COVID-19: small numbers- big conclusions by Schilling, William HK, Callery, James J., Chandna, Arjun, Hamers, Raph L, Watson, James A, White, Nicholas J

    Published in Wellcome open research (2021)
    “…The World Health Organization living guideline on drugs to prevent COVID-19 has recently advised that ongoing trials evaluating hydroxychloroquine in…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15